Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgotinib Phase 2a Proof-of-Concept in RA
NCT01384422Phase 2Completed
- Sponsor
- Galapagos NV
- Start
- Jun 2011
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of filgotinib in rheumatoid arthritis (RA), sponsored by Galapagos NV. Started Jun 2011; status: completed.
02
Drugs
filgotinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01384422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01384422.